Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SRSF3P1 is a pseudogene related to the functional splicing factor SRSF3. Pseudogenes are DNA sequences similar to functional genes, but are generally not transcribed or translated into proteins and do not serve known cellular functions. All major biological, therapeutic, and disease-related functions in the literature refer to SRSF3 (Serine/arginine-rich splicing factor 3), a key regulator of RNA splicing, gene expression, cell cycle, and oncogenesis. SRSF3P1 itself is not a druggable protein nor a molecular target in the current biomedical literature. If you are seeking therapeutic or biological insights, use SRSF3 (Serine/arginine-rich splicing factor 3, SRp20) as the canonical target. SRSF3P1 is a non-coding pseudogene and should not be used unless your context specifically requires study of pseudogene transcription/epigenetics. Summary: SRSF3P1 is a pseudogene, not a protein-coding drug target. Functional and therapeutic literature applies to SRSF3, not SRSF3P1[1][2][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRSF3 pseudogene 1 (SRSF3P1).